Cargando…

Using Cariprazine to Ameliorate Negative Symptoms and Metabolic Side Effects of Clozapine and Paliperidone – Clinical Cases

INTRODUCTION: Cariprazine is a third-generation antipsychotic approved in Europe in 2017 for the treatment of schizophrenia. It presents distinct pharmacodynamic properties, such as D3/D2 partial agonism, preferential binding to D3 receptors, antagonism at the serotonin 5-HT2A and 5-HT2B receptors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viegas, Filipa, Ferreira, Tiago, Campos, Cláudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192349/ https://www.ncbi.nlm.nih.gov/pubmed/35712695 http://dx.doi.org/10.2147/NDT.S343747

Ejemplares similares

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report
por: Everte, I., et al.
Publicado: (2022)

Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series
por: Duque-Yemail, Juan D, et al.
Publicado: (2022)

Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
por: Berardis, Domenico De, et al.
Publicado: (2021)

Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
por: Bogren, Mats, et al.
Publicado: (2022)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
por: Darriba, H. Becerra
Publicado: (2021)

Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study
por: Pappa, Sofia, et al.
Publicado: (2022)

Cariprazine as a treatment for negative psychotic symptoms in first-episode psychosis: case series
por: Demjaha, Arsime, et al.
Publicado: (2022)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Vasiliu, Octavian
Publicado: (2021)

Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone
por: Agarwal, Paras, et al.
Publicado: (2021)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Cariprazine pharmacokinetics
Publicado: (2022)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome
por: Weise, Judith, et al.
Publicado: (2022)

A Focused Review of the Metabolic Side-Effects of Clozapine
por: Yuen, Jessica W. Y., et al.
Publicado: (2021)

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence
por: Rancans, E., et al.
Publicado: (2023)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up
por: Pappa, Sofia, et al.
Publicado: (2023)

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
por: Molnar, Maria Judit, et al.
Publicado: (2022)

The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
por: Csehi, Reka, et al.
Publicado: (2023)

Metabolic Disturbances, Side Effect Profile and Effectiveness of Clozapine in Adolescents
por: Grover, Sandeep, et al.
Publicado: (2016)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2008)

Successful treatment using combined electroconvulsive therapy and oral paliperidone for clozapine-resistant schizophrenia: A case report
por: Varlam, C. I., et al.
Publicado: (2023)

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study
por: Rancans, Elmars, et al.
Publicado: (2021)

Early-Onset Schizophrenia With Predominantly Negative Symptoms: A Case Study of a Drug-Naive Female Patient Treated With Cariprazine
por: Molnar, Maria Judit, et al.
Publicado: (2020)

Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms
por: Vrublevska, Jelena
Publicado: (2023)

Crippling Side Effects Induced by Paliperidone Palmitate Treatment: A Case Report
por: Al-Mahrouqi, Tamadhir, et al.
Publicado: (2021)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
por: Demirci, Kadir, et al.
Publicado: (2015)

Case Report: Long-Acting Oral Cariprazine
por: Dyrmishi, Emanuela, et al.
Publicado: (2022)

Case series: Cariprazine in early-onset schizophrenia
por: Ivanova, Elena, et al.
Publicado: (2023)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel, Thomas
Publicado: (2021)

Defining the therapeutic reference range for cariprazine
por: Kapás, M., et al.
Publicado: (2023)

The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
por: Laszlovszky, I., et al.
Publicado: (2021)

Clozapine-induced bicytopenia: An unusual side effect
por: Faye, Abhijeet D., et al.
Publicado: (2018)

Time of onset of hematological side effects with Clozapine
por: Ktari, H., et al.
Publicado: (2022)

F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY
por: Mathews, Maju, et al.
Publicado: (2018)

Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
por: Szatmári, Balázs, et al.
Publicado: (2020)

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials
por: Do, André, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73l3c6danagiukmeg870dv9ar4